2008
DOI: 10.2337/dc08-zb10
|View full text |Cite
|
Sign up to set email alerts
|

American College of Endocrinology Pre-Diabetes Consensus Conference: Part One

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
13
1
2

Year Published

2008
2008
2020
2020

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 13 publications
(16 citation statements)
references
References 87 publications
0
13
1
2
Order By: Relevance
“…Prediabetes (PD) is an intermediate stage where plasma glucose falls between normal levels and those of type 2 DM, and can be identified by detecting impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT) [5]. PD is an important risk factor for the development of type 2 DM, micro and macrovascular involvement [6].…”
Section: Introductionmentioning
confidence: 99%
“…Prediabetes (PD) is an intermediate stage where plasma glucose falls between normal levels and those of type 2 DM, and can be identified by detecting impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT) [5]. PD is an important risk factor for the development of type 2 DM, micro and macrovascular involvement [6].…”
Section: Introductionmentioning
confidence: 99%
“…La probabilidad anual de desarrollar el cuadro clínico de DM con estos valores alterados es 10% por año, sobre todo si va asociada a obesidad. Pero la implementación de cambios en el estilo de [7][8][9] vida, ejercicios y medicamentos para prevenir o retrasar la aparición de la DM. En el Paraguay la prevalencia 10 de DM en la población general mostró un aumento significativo de 6,5 a 9,7% en un intervalo mayor a 10 años.…”
Section: Introductionunclassified
“…La terapia medicamentosa aún no está recomendada en la etapa de preenfermedad, por lo que el costo del tratamiento preventivo no puede superar a 7,42 los beneficios de la enfermedad establecida.…”
Section: Introductionunclassified
“…He reviewed evidence that ␤-cell volume on autopsy studies is inversely proportional to fasting glucose, decreasing by half at the stage of impaired glucose tolerance (IGT), with further progression in individuals with type 2 diabetes (21). Given the evidence of retinopathy and neuropathy in IGT in the Diabetes Prevention Program (DPP) reviewed by Ratner (see part one of this series [22]), DeFronzo suggested, "We need to intervene early. .…”
mentioning
confidence: 99%